| Tag | Content |
|---|
EnhancerAtlas ID | HS022-01199 |
Organism | Homo sapiens |
Tissue/cell | CD4+ |
Coordinate | chr1:178541690-178543520 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| LMX1B | MA0703.2 | chr1:178543159-178543170 | AATTTAATTAA | + | 6.32 | | ZNF263 | MA0528.1 | chr1:178543486-178543507 | TTCCCTCTCCTTCCATCCTCC | - | 6.36 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_10954 | chr1:178541393-178555600 | CD20 | | SE_58337 | chr1:178530312-178588990 | Ly1 | | SE_59705 | chr1:178531640-178578875 | Ly4 | | SE_60623 | chr1:178541649-178553910 | DHL6 | | SE_61035 | chr1:178541637-178589311 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GCAGTGAGCT GAGATCATGC CACTGCACTG CAGCCTGGTG ACAGAGGGAG ACTCTGTCTC 60
TAAATAAATA AGTAAATAAA TAAAAATCAG GCAACCTGAC CCTAAATCAC TTTGCCTTAC 120
AGAATAGGAA ACTGGGGTTC AGAGAAGTTA AAGAACTCTG AGGTCATGTA GCTGGCTAGT 180
GCAGATCTGT CTGGCCCCAG AGCTTATCCT TTCCCCCTTA GTTGCCCCAA ATCTATCTTA 240
CCCTGGTGGG CCACCAGGAG GAGTGACAAA AAATAGACCT GAATGTTTAA GCTGAAAACA 300
CCTGGAAGAG GCCAATTAAG ATACCTAAAT AAAGTGCCCT TTAAACAACC AGGACAACAA 360
TAAATATCTG AAGGTCAGCA AATGAATCAA AATGCTAGAT AATCAGAAAG AGCTATTAAG 420
GAACAAACAC TGTAGAACTT GCTTGTATAC TGGAGCAGGA TTAAGGAACT GGTTAGGTCA 480
AGGCTGTGAA TTGCCATTAA GAAATCAGTA TTAAAAGTTG CTGTCTTGAT TGGGACTCTA 540
AGTACCTTCT GTTTTGTTTT TCCCACTAAT TTCCCAGACT CCCAGGCCCT TCCAACCAGT 600
CAGTAGGTTA GTATTAATCC CTTTAACCCC CATACATCCC TGGGGTGGGG TTAGGCCCAG 660
TTAAACCCAG GCCTCAAGGT TCCATTGAAC CCACCCAAGG TCTGTGGGAA GAGACCCCAG 720
TGCCTGTCTT GACTCACCCA TTTCTTTTCT TTGTCAGCTC TTGTTTTTCT TCACCTTGGA 780
TTATCCTGAA GCTCAGTTAA TTGAGTCCTG AATAAGTAAG GGCATGTTGT AATTCCAAAT 840
TCAAGACAAG TTTTCTATTT AACCAGAGGT CCTTTTCATG TTACTCACAG AGGAGACACT 900
CAAGACGGGG TATCAATGGA ATTGCAGTTT GATAACTAAA CAGAAGCACA CTTGAAACTC 960
TGGTGACTAA TACAGCCCCA TTCACACCTA CCGAAAGACA ATCCCCTGCT CTATCTGTGG 1020
TTTGAATCGA TCACAAAAAA CACAGATTTG CTTCCAGCAG CTAAAGTAAT TTTAGTTTTA 1080
TCAAATAGTG TATGTTTGGG TTTCTAGAGT TAAAAAAAAA CTCATGCTTG GACCTTGGGC 1140
ACCCATTGGA AGCTGCCTAT CTGTTCCCAC CCTTGCTGCT AGGACTCTCC TCACTGCTGT 1200
TAGCACACAG TGGGTTTCTA CTGCTAAGAA CTCCCTCCTC AACCCTGCCC TGGCACCCTA 1260
AAAATGACCT GTGCTGATAC CTTCTCTCCC CTGCTCCCCA TACACCCACA GGTGCAGGAA 1320
CAGCTCCAGC TCTGCCTTTG TCCCGCGCTT TGAGCTTTTT TCAGGCTTCA CCACTGCTCT 1380
TTCTTTGGCT TCATACTTGG GTTCTTTTTC TGTACAGGGT TAACAACTAT ATCATGAGAA 1440
TATTAGTTAG ATTCCATTTA ACTTTTTACA ATTTAATTAA ATAGAGGTAA TTATAGATTC 1500
ACATCGGGTT GTAAGAAATA ATACAGAGAG ATACAATGTG TCTTTTATCC ACAGTTTCCT 1560
TCCAATGGTA ACATCTTACA AAACTCTAGT ATGTGCAATA TTACAACTAG GAAATTGATG 1620
GTACAATCCA TAGATCTTGA TCAGATTTCC CTCCTGTCTT ACATTTACTC TGTGTGTGTG 1680
TGTGTGTGTG TGTGTGTGCA CGTGCACGTG TATTTAATTC TATGCCATTT TATCACATGT 1740
GGAGGTTTGT ATATCAATCA CCATCTCTTA TGTTGCCTTT TTGTAACATA ATCTATTTCC 1800
CTCTCCTTCC ATCCTCCACC CCCTGGCCCT 1830
|
